These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36376079)

  • 1. A Systematic Review of Optogenetic Vision Restoration: History, Challenges, and New Inventions from Bench to Bedside.
    Stefanov A; Flannery JG
    Cold Spring Harb Perspect Med; 2023 Jun; 13(6):. PubMed ID: 36376079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mini-Review: Cell Type-Specific Optogenetic Vision Restoration Approaches.
    Chaffiol A; Duebel J
    Adv Exp Med Biol; 2018; 1074():69-73. PubMed ID: 29721929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optogenetic Strategies for Vision Restoration.
    Lu Q; Pan ZH
    Adv Exp Med Biol; 2021; 1293():545-555. PubMed ID: 33398841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degenerated Cones in Cultured Human Retinas Can Successfully Be Optogenetically Reactivated.
    Kamar S; Howlett MHC; Klooster J; Graaff W; Csikós T; Rabelink MJWE; Hoeben RC; Kamermans M
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optogenetic restoration of high sensitivity vision with bReaChES, a red-shifted channelrhodopsin.
    Too LK; Shen W; Protti DA; Sawatari A; A Black D; Leamey CA; Y Huang J; Lee SR; E Mathai A; Lisowski L; Y Lin J; C Gillies M; Simunovic MP
    Sci Rep; 2022 Nov; 12(1):19312. PubMed ID: 36369267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice.
    Macé E; Caplette R; Marre O; Sengupta A; Chaffiol A; Barbe P; Desrosiers M; Bamberg E; Sahel JA; Picaud S; Duebel J; Dalkara D
    Mol Ther; 2015 Jan; 23(1):7-16. PubMed ID: 25095892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV Induced Expression of Human Rod and Cone Opsin in Bipolar Cells of a Mouse Model of Retinal Degeneration.
    McClements ME; Staurenghi F; Visel M; Flannery JG; MacLaren RE; Cehajic-Kapetanovic J
    Biomed Res Int; 2021 Feb; 2021():1-8. PubMed ID: 35465048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optogenetic approaches to therapy for inherited retinal degenerations.
    De Silva SR; Moore AT
    J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optogenetic Therapy for Visual Restoration.
    Sakai D; Tomita H; Maeda A
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optogenetics for visual restoration: From proof of principle to translational challenges.
    Lindner M; Gilhooley MJ; Hughes S; Hankins MW
    Prog Retin Eye Res; 2022 Nov; 91():101089. PubMed ID: 35691861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Ophthalmic Optogenetics: Approaches and Applications.
    Prosseda PP; Tran M; Kowal T; Wang B; Sun Y
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optogenetic targeting of AII amacrine cells restores retinal computations performed by the inner retina.
    Khabou H; Orendorff E; Trapani F; Rucli M; Desrosiers M; Yger P; Dalkara D; Marre O
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101107. PubMed ID: 37868206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar cell targeted optogenetic gene therapy restores parallel retinal signaling and high-level vision in the degenerated retina.
    Kralik J; van Wyk M; Stocker N; Kleinlogel S
    Commun Biol; 2022 Oct; 5(1):1116. PubMed ID: 36266533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approaches to vision restoration using optogenetic therapy.
    Parnami K; Bhattacharyya A
    Front Cell Neurosci; 2023; 17():1236826. PubMed ID: 37663125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of Vision and Retinal Responses After Adeno-Associated Virus-Mediated Optogenetic Therapy in Blind Dogs.
    Nikonov S; Aravand P; Lyubarsky A; Nikonov R; Luo AJ; Wei Z; Maguire AM; Phelps NT; Shpylchak I; Willett K; Aleman TS; Huckfeldt RM; Ramachandran PS; Bennett J
    Transl Vis Sci Technol; 2022 May; 11(5):24. PubMed ID: 35604672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsins for vision restoration.
    Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D
    Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optogenetics for retinal disorders.
    Henriksen BS; Marc RE; Bernstein PS
    J Ophthalmic Vis Res; 2014; 9(3):374-82. PubMed ID: 25667740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances.
    McClements ME; Staurenghi F; MacLaren RE; Cehajic-Kapetanovic J
    Front Neurosci; 2020; 14():570909. PubMed ID: 33262683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empowering Retinal Gene Therapy with a Specific Promoter for Human Rod and Cone ON-Bipolar Cells.
    Hulliger EC; Hostettler SM; Kleinlogel S
    Mol Ther Methods Clin Dev; 2020 Jun; 17():505-519. PubMed ID: 32258214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration.
    Wood EH; Kreymerman A; Kowal T; Buickians D; Sun Y; Muscat S; Mercola M; Moshfeghi DM; Goldberg JL
    Prog Retin Eye Res; 2023 Sep; 96():101153. PubMed ID: 36503723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.